Chronic administration of carvedilol improves cardiac function in 6-month-old Syrian cardiomyopathic hamsters.
作者： Nildris Cruz , Luz Arocho , Luis Rosario , Maria J. Crespo
DOI: 10.1159/000103254
关键词:
摘要: Heart failure (HF) is a multifactorial and progressive disease that has been linked to activation of the renin-angiotensin sympathetic systems. In recent years, β-blockers have shown impro
sci-hub.se 参考文章(37)
M J Sole, P A Daly, Myocardial catecholamines and the pathophysiology of heart failure. Circulation. ,vol. 82, ,(1990)
E. W. Gertz, Cardiomyopathic Syrian Hamster: A Possible Model of Human Disease1 Progress in Experimental Tumor Research. ,vol. 16, pp. 242- 260 ,(1972) , 10.1159/000393374
Sharon Ann Hunt, None, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology. ,vol. 46, pp. 1116- 1143 ,(2005) , 10.1016/J.JACC.2005.08.022
Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Cardiovascular Drugs and Therapy. ,vol. 11, pp. 247- 256 ,(1997) , 10.1023/A:1007735729121
TIAN L. YUE, PAUL G. LYSKO, FRANK C. BARONE, JUAN L. GU, ROBERT R. RUFFOLO, GIORA Z. FEUERSTEIN, Carvedilol, A New Antihypertensive Drug with Unique Antioxidant Activity: Potential Role in Cerebroprotection Annals of the New York Academy of Sciences. ,vol. 738, pp. 230- 242 ,(2006) , 10.1111/J.1749-6632.1994.TB21808.X
Marı́a J Crespo, Walmor C De Mello, Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters European Journal of Pharmacology. ,vol. 420, pp. 133- 141 ,(2001) , 10.1016/S0014-2999(01)01006-8
Sonia Goineau, Danielle Pape, Pascal Guillo, Marie-Paule Ramée, Eric Bellissant, Hemodynamic and histomorphometric characteristics of dilated cardiomyopathy of Syrian hamsters (Bio TO-2 strain). Canadian Journal of Physiology and Pharmacology. ,vol. 79, pp. 329- 337 ,(2001) , 10.1139/Y01-003
Volker Straub, Franck Duclos, David P. Venzke, Jane C. Lee, Susan Cutshall, Cynthia J. Leveille, Kevin P. Campbell, Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster American Journal of Pathology. ,vol. 153, pp. 1623- 1630 ,(1998) , 10.1016/S0002-9440(10)65751-3
Milton Packer, The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology. ,vol. 20, pp. 248- 254 ,(1992) , 10.1016/0735-1097(92)90167-L
A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, F. Hanaoka, Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 13873- 13878 ,(1997) , 10.1073/PNAS.94.25.13873